http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2407921-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76195fd1cd08192222699d8e7a88c231 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 |
| filingDate | 1978-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1979-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2407921-A1 |
| titleOfInvention | NEW 7-OXA-BICYCLOHEPTANES AND -BICYCLOHEPTENES, USEFUL IN PARTICULAR AS CARDIOVASCULAR AGENTS, AND THEIR PREPARATION PROCESS |
| abstract | THE MEDICINAL PRODUCTS ACCORDING TO THE INVENTION RESPOND TO THE GENERAL FORMULAS: (CF DRAWING IN BOPI) IN WHICH R IS A HYDROGEN ATOM OR AN ALKYL GROUP; R IS A -CHO, -CHOH OR -CHCH-R- (LOWER ALKYLENE) -CH GROUP; R IS A CETO OR HYDROXYMETHYL GROUP; AND THE INTERRUPTED LINE IS AN OPTIONAL ADDITIONAL LINK, AND X IS EQUAL TO 0 OR 1. APPLICATION AS CARDIOVASCULAR AGENTS, ESPECIALLY AS BLOOD PLATE AGGLOMERATION INHIBITORS AT DAILY DOSES OF APPROXIMATELY 1 TO 100MG PER ESPECIALLY IN TABLETS, CAPSULES, SOLUTIONS OR SUSPENSIONS CONTAINING APPROXIMATELY 5 TO 500MG OF ACTIVE INGREDIENT PER DOSAGE UNIT. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5383287-A |
| priorityDate | 1977-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.